Dyee Capital
49
46M
43
7
0.12
- Areas of investment
Summary
The main office of represented VC is situated in the Xiamen. The company was established in Asia in China.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Dyee Capital, startups are often financed by RMB Funds, Legend Capital, China Growth Capital. The meaningful sponsors for the fund in investment in the same round are Lilly Asia Ventures, Capital Today, Xiamen C&D Corporation. In the next rounds fund is usually obtained by Silicon Valley Bank, Qualcomm Ventures, Legend Capital.
Among the most popular portfolio startups of the fund, we may highlight FineEx, Hebaodan, Borns Robot. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are E-Commerce, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
This organization was formed by Dezhen Zhu.
The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 49
- Lead investments
- 7
- Follow on index
- 0.12
- Investments by industry
- Health Care (19)
- Pharmaceutical (16)
- Biotechnology (15)
- Medical (11)
- Biopharma (8) Show 43 more
- Investments by region
-
- China (43)
- United States (4)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 94M
- Group Appearance index
- 0.88
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cloudbreak Therapeutics | 01 Jan 2022 | Biotechnology, Health Care | Late Stage Venture | 130M | United States, California, Irvine |
| Yinuo Pharmaceutical | 23 Dec 2021 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 120M | Hangzhou, Zhejiang, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.